A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 2, 1996, Pages 445-450

  Hsue, Victor ^a   Wong, C Shun ^a,c   Moore, Malcolm ^a   Erlichman, Charles ^a   Cummings, Bernard J ^a   Macleod, Marcia ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

5 Fluorouracil; Folinic acid; Pancreatic carcinoma; Radiotherapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; FEMALE; GALLBLADDER CARCINOMA; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PANCREAS CARCINOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

EID: 0030051964     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02032-2     Document Type: Article

References (27)

1. Bruckner, H. W.; Crown, J. Leucovorin and 5FU as a treatment for disseminated cancer of pancreas and unknown primary Tumors. Cancer Res. 48:5570; 1988.
2. Cancer facts & figures - 1994 American Cancer Society.
3. Carter, S. K. The integration of chemotherapy into combined modality approach for cancer treatment. Cancer Treat. Rev. 3:193; 1975.
4. Evans, D. B.; Byrd, D. R.; Mansfield, P. Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Am. J. Clin. Oncol. (C.C.T.) 14:359-364; 1991.
5. Evans, D. B.; Rich, T. A.; Byrd, D. R.; Mansfield, P. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch. Surg. 127:1335-1339; 1992.
6. Evans, R. M.; Laskin, J. D. Effect of excess of folates and deoxyinosine in the activity and site of action of 5-fluorouracil. Cancer Res. 41:3288-3295; 1981.
7. Gastrointestinal Tumor Study Group (G.I.T.S.G.). Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose radiation alone, moderate dose radiation + 5FU and high dose radiation + 5FU. Cancer 48:1705-1710; 1981.
8. Gastrointestinal Tumor Study Group, G.I.T.S.G. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010; 1987.
9. Gastrointestinal Tumor Study Group, G.I.T.S.G. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined modality therapy to chemotherapy alone. J. Natl. Cancer Inst. 80:751-755; 1988.
10. Kaiser, M. H.; Ellenberg, S. S.; G.I.T.S.G. Pancreatic cancer: Adjuvant combined treatment and chemotherapy after curative resection. Arch. Surg. 120:899; 1985.
11. Griffin, J. F.; Smalley, S. R.; Jewell, W. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1:56-61; 1990.
12. Heidelberger, C.; Griesback, L. Studies on fluorinated pyrimidines: Effects on transplanted tumor. Cancer Res. 18:305-317; 1958.
13. Jeekel, J.; Treurniet-Donker, A. D. Treatment perspective in locally advanced unresectable pancreatic cancer. Br. J. Surg. 78:1332-1334; 1991.
14. Jessup, J. M.; Steele, G.; Mayer, R. J. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch. Surg. 128(May):559-564; 1993.
15. Klaasen, D. J.; MacIntyre, J. M. Treatment of locally unresectable cancer of stomach and pancreas: A randomised comparison of 5-Fluorouracil alone with radiation plus concurrent and maintenance 5FU. J. Clin. Oncol. 3:373-378; 1985.
16. Komaki, R.; Wadler, S.; Peters, T. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas: A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group protocol 8801). Cancer 69(11):2807-2812; 1992.
17. Komaki, R.; Wilson, J. F.; Cox, J. D. Carcinoma of pancreas: Result of irradiation for unresectable lesions. Int. J. Radiat. Oncol. Biol. Phys. 6:209-212; 1980.
18. McCracken, J. D.; Ray, P.; Heilbrum, L. K. 5-Fluorouracil, methyl-CCNU and radiotherapy with or without testosterone for localised adenocarcinoma of exocrine pancreas. Cancer 46:1518-1522; 1980.
19. Moertel, C. T.; Childs, D. S.; Reitemeier, R. J.; Colby, M. Y.; Holbrook, M. A. Combined 5FU and supervoltage radiation of unresectable pancreatic carcinoma. Lancet 2:865-867; 1969.
20. Moertel, C.; Gunderson, L.; Mailliard, J. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual or recurrent gastrointestinal carcinoma. J. Clin. Oncol. 12(1):21-27; 1994.
21. Nagai, H.; Kuroda, A. Lymphatic and local spread of T1 and T2 pancreatic cancer. Ann. Surg. 204:65-71; 1986.
22. Nakajima, Y.; Miyainoto, T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res. 39:3763-3767; 1979.
23. Raju, P. I.; Maruyama, Y.; MacDonald, J.; Desimone, P. Treatment of unresectable pancreatic carcinoma using irradiation with concurrent intravenous 5FU infusion therapy. Cancer Invest. 6:263-266; 1988.
24. Rich, T. A. Radiation therapy for pancreatic cancer: Eleven years' experience at the JCRT. Int. J. Radiat. Oncol. Biol. Phys. 11:759-763; 1985.
25. Schifeling, D. J.; Konski, A. A.; Howard, J. M.; Dobelbower, R. R. Jr.; Merrick, H. W.; Skeel, R. T. Radiation therapy and 5-Fluorouracil modulated by leucovorin for adenocarcinoma of the pancreas: A phase I study. Int. J. Pancreatol. 12:239-243; 1992.
26. Whittington, R.; Dolbelbower, R. R.; Mohiuddin, M. Radiotherapy of unresectable pancreatic carcinoma: A six-year experience with 104 patients. Int. J. Radiat. Oncol. Biol. Phys. 7:1639-1644; 1981.
27. Whittington, R.; Solin, L. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 54:1991-1998; 1984.